Administer via intravenous infusion using a central or peripheral vein depending on the final dextrose concentration. Hypertonic solutions with dextrose concentrations above 10% must be infused through a central venous catheter with the tip in the superior vena cava. For peripheral administration, dilute to a final concentration of 5% to 10% for both amino acids and dextrose. The initial infusion rate for adults should be 2 mL/min, adjusted based on patient tolerance and glucose levels. Dual-chamber containers must be thoroughly mixed by activating the peel seal and inverting before use. Admixtures should be prepared under strict aseptic conditions in a laminar flow hood and used within 24 hours. Monitor blood urea nitrogen and electrolytes frequently, especially in patients with renal or hepatic impairment, as dose adjustments or discontinuation may be necessary to prevent hyperammonemia or fluid overload. Pediatric patients require careful monitoring for aluminum toxicity and ammonia levels.

Details coming soon